Sahil Sharma Profile picture
Fascinating that the most complex machine in this universe became self aware Nothing i share is a buy/sell reco. I'm not a sebi registered advisor.

Jan 28, 2022, 9 tweets

Laurus labs concall happened right now.

Very interesting commentary from dr chava sir. 🐂

My key takeaways 👇
Disclaimer: biased, i am adding today. 🙏

1. Revenue is only 933cr in this Q. 1 B$ sales in fy23 guidance is in tact

In b/w lines: you must have heard by now, the arv sales are down due to inventory stocking by laurus customers. Global customers like global fund did inventory stocking last year. So sale has been low

Expecting arv api sales to normalize to 400cr/Q level Q4 onwards
Why is 1B$ revenue 🎯 in tact ?

Coz capex is done. Formulation capacity will double in next 1-2 Q. Non arv biz is growing fast. Cdmo is up 60% YoY. Some other api division approvals got delayed.

2. Cdmo is growing fast. Really fast.

In b/w lines: Already it's at around 800cr runrate. Expecting cdmo to be 25% of revenue in 3 years time. This works out to roughly 3x growth in cdmo (bio + chem cdmo) in 3 years. The cdmo trend is quite secular

3. Laurus bio did 25cr / Q runrate for last 2 Q. Future is bright.

In b/w lines: Can do 40cr in next few Q as new fermenter comes online. Current capacity is around 200 KL.

LAURUS setting up 1M L capacity but the plant has space for 3M L capacities

Stage 1 already has 500cr revenue potential scaling directly current capacity.

Total revenue potential might be around 1500cr + to be realised in next many years.

Working closely with clients to design & build the Greenfield capacity.

4. Margins. Gross are up 4-5%. Operating are down 4%

Operating deleverage has resulted in operating margin going down. Some of it is due to non utilization of new capacity

Gross margin are up due to better product mix. Arv used to be 80% of sales not so long ago. Now it's 50%

Arv api are the lowest value product. Lowest gross margin product. Cdmo is significantly higher gross margin for laurus than arv. Even non Ari api are significantly higher margin. Confident of maintaining 30% ebitda margins.

<End of notes>

I am adding, biased. Not a reco.

Please don't take anything i share as a reco. I am not an investment advisor do your own due diligence. 🙏🙏

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling